ContractSale and Purchase Agreement • February 27th, 2014 • Mylan Inc. • Pharmaceutical preparations
Portions of this exhibit have been omitted and filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request. Omissions are designated as ***.
THE EXECUTIVE NONQUALlFIED "EXCESS" PLAN ADOPTION AGREEMENTAdoption Agreement • February 27th, 2014 • Mylan Inc. • Pharmaceutical preparations
THIS AGREEMENT is the adoption by MYLAN INTERNATIONAL HOLDINGS, INC. (the "Company") of the Executive Nonqualified Excess Plan ("Plan").
MYLAN INC. AMENDED AND RESTATED INDEMNIFICATION AGREEMENTIndemnification Agreement • February 27th, 2014 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
This Amended and Restated Indemnification Agreement (the “Agreement”) is made this __ day of _______, 2013, by and between Mylan Inc., a Pennsylvania corporation (the “Corporation”), and __________ (“Indemnitee”). This Agreement amends and restates in its entirety the Indemnification Agreement previously entered into between the Corporation and Indemnitee.
MYLAN INC. STOCK OPTION AGREEMENTStock Option Agreement • February 27th, 2014 • Mylan Inc. • Pharmaceutical preparations
__________ (the “Optionee”) is granted, effective as of the grant date, options (the “Options”) to purchase shares of Common Stock ("Common Stock" or "Shares") of Mylan Inc. (the "Option Shares") pursuant to the 2003 Long-Term Incentive Plan, as amended to date (the “Plan”) of Mylan Inc. (the "Corporation"). The Options are subject to the terms and conditions set forth below and in the Plan, which is a part of this Stock Option Agreement (the “Agreement”). To the extent that there is a conflict between the terms of the Plan and this Agreement, the terms of the Plan shall govern. Any term not defined herein shall have the meaning assigned to such term in the Plan.
